Regional Phenotyping of CF and Non-CF Bronchiectasis
Recruiting now
Conditions studied: Cystic Fibrosis, Non-CF Bronchiectasis
In brief
The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based markers can forecast pathophysiology prior to spirometric changes.
Key facts
- Study ID
- NCT04793867
- Run by
- Children's Hospital Medical Center, Cincinnati
- People needed
- 100
- Starts
- 2021-02-08
- Expected to finish
- 2027-03-31
- Last updated by the study team
- 2025-02-20
Who can join
Age: 5 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- CF Patients: Diagnosis of CF based on sweat chloride >60 mMol/l
- Presence of two disease causing CFTR mutations, or end organ manifestations of disease.
- Age minimum 5 years.
- Care provided by the CCHMC CF Care Center or other regional CF Care Centers if required to achieve recruitment goals.
You may not qualify if…
- Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal implants, claustrophobia, etc.)
- Pregnancy or lactation.
- Inclusion Criteria of Healthy Subjects:
- Subjects 5 years of age and older with no known history of cardiopulmonary disease.
- Exclusion Criteria of Healthy Subjects:
- Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal implants, claustrophobia, etc.)
- Pregnancy or lactation.
Where it is running
- Penny New — Cincinnati, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.